ArticleCancer immunology, immunotherapy : CII2024

Identification of an HLA-A*11:01-restricted neoepitope of mutant PIK3CA and its specific T cell receptors for cancer immunotherapy targeting hotspot driver mutations.

Meiying Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.